AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33914319 — intervention group
Group type: EXPERIMENTAL
Intervention: TachoSil (collagen patches coated with human coagulation factors)
Number of subjects: 50
Study 33914319 — intervention group
Group type: COMPARATOR
Intervention: Control (side without TachoSil applied)
Number of subjects: 50
Study 33914319 — intervention group
Group type: EXPERIMENTAL
Intervention: TachoSil
Number of subjects: 50
Study 33914319 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study 35818060 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic medial patellofemoral ligament reconstruction
Number of subjects: 0
Study 35818060 — intervention group
Group type: COMPARATOR
Intervention: Static medial patellofemoral ligament reconstruction
Number of subjects: 0
Study 34129024 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-to-peer (P2P) support
Number of subjects: 448
Study 34129024 — intervention group
Group type: COMPARATOR
Intervention: Standard community services (SCS)
Number of subjects: 448
Study 32891289 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercise for six days
Number of subjects: 60
Study 32891289 — intervention group
Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 60
Study 35312016 — intervention group
Group type: EXPERIMENTAL
Intervention: Quartz diorite
Number of subjects: 24
Study 35312016 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhomb porphyry
Number of subjects: 24
Study 35312016 — intervention group
Group type: COMPARATOR
Intervention: Control dust (lactose)
Number of subjects: 24
Study 33970657 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic therapy
Number of subjects: 100
Study 33970657 — intervention group
Group type: COMPARATOR
Intervention: Cognitive therapy
Number of subjects: 100
Study 32442300 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaphase cytogenetic abnormalities, PCPro, FISH gain 1q
Number of subjects: 483
Study 32442300 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk scoring system based on R-ISS and age
Number of subjects: 483
Study 32442300 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaphase cytogenetics
Number of subjects: 483
Study 32442300 — intervention group
Group type: EXPERIMENTAL
Intervention: PCPro and FISH gain 1q
Number of subjects: 483
Study 35467904 — intervention group
Group type: EXPERIMENTAL
Intervention: home‐MCT
Number of subjects: 108
Study 35467904 — intervention group
Group type: EXPERIMENTAL
Intervention: usual CR plus home‐MCT
Number of subjects: 108
Study 35467904 — intervention group
Group type: COMPARATOR
Intervention: telephone support calls
Number of subjects: 108
Study 33940043 — intervention group
Group type: EXPERIMENTAL
Intervention: 1L-PEG+ASC
Number of subjects: 388
Study 35337389 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle advice with or without metformin
Number of subjects: 60
Study 35337389 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 60
Study 36153530 — intervention group
Group type: EXPERIMENTAL
Intervention: Target MAP of 80-85 mmHg (high-target)
Number of subjects: 0
Study 36153530 — intervention group
Group type: COMPARATOR
Intervention: Target MAP of 65-70 mmHg (control)
Number of subjects: 0
Study 33766510 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (RTX)
Number of subjects: 0
Study 33766510 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study 32387007 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular midazolam
Number of subjects: 150
Study 32387007 — intervention group
Group type: COMPARATOR
Intervention: Buccal midazolam
Number of subjects: 150
Study 34618478 — intervention group
Group type: EXPERIMENTAL
Intervention: SOLAR group program (n = 15)
Number of subjects: 30
Study 34618478 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (n = 15)
Number of subjects: 30
Study 33789580 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine 12.5 mg once daily at bedtime for a maximum of 7 days
Number of subjects: 122
Study 33789580 — intervention group
Group type: COMPARATOR
Intervention: Placebo once daily at bedtime for a maximum of 7 days
Number of subjects: 122
Study 33789580 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 122
Study 33789580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 33186500 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 105
Study 33186500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 33354559 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective modified Sugiura procedure (sMSP group, n=30)
Number of subjects: 60
Study 33354559 — intervention group
Group type: COMPARATOR
Intervention: Modified Sugiura procedure (MSP group, n=30)
Number of subjects: 60
Study 36133576 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-based LSVT-BIG intervention (30 minutes of conventional occupational therapy and 40 minutes of task-based LSVT-BIG program, once a day, 5 times a week for 4 weeks)
Number of subjects: 14
Study 36133576 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-based LSVT-BIG intervention
Number of subjects: 14
Study 36133576 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 minutes of conventional occupational therapy and 40 minutes of relaxation and stretching, once a day, 5 times a week for 4 weeks)
Number of subjects: 14
Study 36133576 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 14
Study 34593374 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual care with RAM technology (n=451)
Number of subjects: 905
Study 34593374 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=454)
Number of subjects: 905
Study 32999157 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trials
Number of subjects: 0
Study 32999157 — intervention group
Group type: EXPERIMENTAL
Intervention: Published case reports
Number of subjects: 0
Study 32999157 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous reports
Number of subjects: 0
Study 616787617 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with the Key-Box (10-day training, 10 different exercises)
Number of subjects: 16
Study 616787617 — intervention group
Group type: COMPARATOR
Intervention: Nontraining control group (no training)
Number of subjects: 16
Study 616787617 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with the Key-Box
Number of subjects: 16
Study 35198517 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized information and breathing advice only (IBA)
Number of subjects: 0
Study 35198517 — intervention group
Group type: EXPERIMENTAL
Intervention: IBA plus inspiratory muscle training
Number of subjects: 0
Study 35198517 — intervention group
Group type: EXPERIMENTAL
Intervention: IBA plus speech therapy
Number of subjects: 0
Study 35198517 — intervention group
Group type: EXPERIMENTAL
Intervention: IBA plus inspiratory muscle training and speech therapy
Number of subjects: 0
Study 35198517 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (surgical)
Number of subjects: 0
Study 35198517 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive laser supraglottoplasty
Number of subjects: 0
Study 35198517 — intervention group
Group type: COMPARATOR
Intervention: No surgery
Number of subjects: 0
Study 32634673 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulipristal acetate (UPA)
Number of subjects: 55
Study 32634673 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone agonists (GnRHa)
Number of subjects: 55
Study 36280988 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual lumbar decompression, lumbar mobilisation, hot packs, TENS, and exercise therapy (Group A - acute)
Number of subjects: 30
Study 36280988 — intervention group
Group type: COMPARATOR
Intervention: Lumbar mobilisation, hot packs, and exercise therapy (Group C - control)
Number of subjects: 30
Study 36280988 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar mobilisation, hot packs, and exercise therapy (Group B - chronic)
Number of subjects: 30
Study 34836345 — intervention group
Group type: EXPERIMENTAL
Intervention: Remotely delivered weight loss intervention (diet and physical activity)
Number of subjects: 159
Study 34836345 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 159
Study 34677151 — intervention group
Group type: EXPERIMENTAL
Intervention: Zufa syrup (7.5 mL every 4 hours for 10 days)
Number of subjects: 116
Study 34677151 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup (identical-looking, 7.5 mL every 4 hours for 10 days)
Number of subjects: 116
Study 34677151 — intervention group
Group type: EXPERIMENTAL
Intervention: Zufa syrup
Number of subjects: 116
Study 34677151 — intervention group
Group type: COMPARATOR
Intervention: Placebo syrup
Number of subjects: 116
Study 33243742 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management combined with uvulopalatopharyngoplasty (UPPP) and cognitive-behavioral-psychological intervention for family weight management
Number of subjects: 60
Study 33243742 — intervention group
Group type: COMPARATOR
Intervention: Uvulopalatopharyngoplasty (UPPP) with conventional management
Number of subjects: 60
Study 33243742 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management combined with uvulopalatopharyngoplasty (UPPP)
Number of subjects: 60
Study 37304656 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 min sitting meditation
Number of subjects: 161
Study 37304656 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min sitting meditation
Number of subjects: 161
Study 37304656 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 min movement meditation
Number of subjects: 161
Study 37304656 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min movement meditation
Number of subjects: 161
Study 37304656 — intervention group
Group type: COMPARATOR
Intervention: Movement meditation (all doses)
Number of subjects: 161
Study 37304656 — intervention group
Group type: COMPARATOR
Intervention: Sitting meditation (all doses)
Number of subjects: 161
Study 34174463 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant human antithrombin gamma (rhAT-gamma)
Number of subjects: 0
Study 34174463 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal, fetal, and neonatal outcomes will be assessed.
Number of subjects: 0
Study 35393864 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention details not available
Number of subjects: 0
Study 33354206 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (atDCS)
Number of subjects: 49
Study 33354206 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 49
Study 35334969 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (1000 mg) with ONS
Number of subjects: 12
Study 35334969 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo with ONS)
Number of subjects: 12
Study 35334969 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin and Control (both with ONS)
Number of subjects: 12
Study 34686614 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Inspiratory Muscle Strength Training (HI)
Number of subjects: 30
Study 34686614 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Inspiratory Muscle Strength Training (MOD)
Number of subjects: 30
Study 34686614 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 35386840 — intervention group
Group type: COMPARATOR
Intervention: Transversus Abdominis Plane Block (TAPB)
Number of subjects: 50
Study 35386840 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus Lumborum Block (QLB)
Number of subjects: 50
Study 35001559 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified reconstituted bilayer matrix (PRBM)
Number of subjects: 40
Study 35001559 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 40
Study 32773446 — intervention group
Group type: EXPERIMENTAL
Intervention: 40U DaxibotulinumtoxinA (DAXI)
Number of subjects: 2691
Study 32795877 — intervention group
Group type: EXPERIMENTAL
Intervention: BPA (Bisphenol A)
Number of subjects: 191
Study 32795877 — intervention group
Group type: EXPERIMENTAL
Intervention: PrPB (Propylparaben)
Number of subjects: 191
Study 32795877 — intervention group
Group type: EXPERIMENTAL
Intervention: EtPB (Ethylparaben)
Number of subjects: 191
Study 32795877 — intervention group
Group type: EXPERIMENTAL
Intervention: Total PBs concentrations
Number of subjects: 191
Study 34587510 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic Evolut PRO/PRO+ self‐expanding device
Number of subjects: 700
Study 34587510 — intervention group
Group type: COMPARATOR
Intervention: Edwards SAPIEN 3/3 Ultra balloon‐expandable device
Number of subjects: 700
Study 34587510 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 700
Study 34153529 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP
Number of subjects: 9
Study 34153529 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-2
Number of subjects: 9
Study 34153529 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP + GLP-2
Number of subjects: 9
Study 34153529 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 9
Study 36066265 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear aligners
Number of subjects: 32
Study 36066265 — intervention group
Group type: COMPARATOR
Intervention: 2 × 4 fixed appliances
Number of subjects: 32
Study 32964381 — intervention group
Group type: EXPERIMENTAL
Intervention: Active iTBS (intensive cerebellar intermittent theta burst stimulation)
Number of subjects: 36
Study 32964381 — intervention group
Group type: COMPARATOR
Intervention: Sham iTBS (placebo control)
Number of subjects: 36
Study 33099502 — intervention group
Group type: EXPERIMENTAL
Intervention: IPFP preservation
Number of subjects: 360
Study 33099502 — intervention group
Group type: COMPARATOR
Intervention: IPFP resection
Number of subjects: 360
Study 32891170 — intervention group
Group type: EXPERIMENTAL
Intervention: (1,3)-β-d-glucan group
Number of subjects: 108
Study 32891170 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 108
Study 34932018 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu-Dotatate
Number of subjects: 195
Study 34932018 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoring model based on risk factors (CgA, creatinine, previous chemotherapy)
Number of subjects: 195
Study 34932018 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoring model cut-off value of 29.7
Number of subjects: 195
Study 33207656 — intervention group
Group type: EXPERIMENTAL
Intervention: GentleWave multisonic System
Number of subjects: 66
Study 33207656 — intervention group
Group type: COMPARATOR
Intervention: Conventional instrumentation and irrigation (positive control)
Number of subjects: 66
Study 33207656 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic irrigation using the Piezon Master 700
Number of subjects: 66
Study 33207656 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic irrigation with the ENDOSONIC Blue
Number of subjects: 66
Study 33207656 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic irrigation with the EDDY
Number of subjects: 66
Study 35772868 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel mental health care bundle co-designed with parents and youth
Number of subjects: 0
Study 35772868 — intervention group
Group type: COMPARATOR
Intervention: Existing care protocols
Number of subjects: 0
Study 32488934 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercise program for 12 weeks
Number of subjects: 0
Study 32488934 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic exercises
Number of subjects: 0
Study 36123866 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33001236 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg levosimendan
Number of subjects: 183
Study 33524994 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocuff Vision
Number of subjects: 1813
Study 33524994 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 1813
Study 34886124 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop group (attended four in-person workshops)
Number of subjects: 15
Study 34886124 — intervention group
Group type: COMPARATOR
Intervention: Home-based group (no workshops)
Number of subjects: 15
Study 32115033 — intervention group
Group type: COMPARATOR
Intervention: Inorganic trace minerals at 1/3 commercial levels (ITM)
Number of subjects: 405
Study 32115033 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein trace minerals at 1/3 commercial levels (TRT)
Number of subjects: 405
Study 35910832 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT‐sMF before WOD
Number of subjects: 12
Study 35910832 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT‐sMF after WOD
Number of subjects: 12
Study 35910832 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT‐sMF before and after WOD
Number of subjects: 12
Study 35910832 — intervention group
Group type: COMPARATOR
Intervention: Placebo before and after WOD
Number of subjects: 12
Study 32794485 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic periodontitis management (not specified in detail)
Number of subjects: 118
Study 32794485 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy controlled diet, cultural background, education, FBG, CAL
Number of subjects: 118
Study 35041042 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.30 mg per kg/day, intravenous, twice daily for 3 days)
Number of subjects: 91
Study 35041042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 33635424 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% Tea Tree Oil (TTO)
Number of subjects: 15
Study 33635424 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% triclosan
Number of subjects: 15
Study 33635424 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0% chlorhexidine
Number of subjects: 15
Study 33635424 — intervention group
Group type: COMPARATOR
Intervention: Reference soap
Number of subjects: 15
Study 33143731 — intervention group
Group type: EXPERIMENTAL
Intervention: TXYF granule
Number of subjects: 120
Study 33143731 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 33143731 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole transcriptome profiling
Number of subjects: 120
Study 34757600 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 100 U/mL with fasting plasma glucose (FPG) targets ≤ 5.6 mmol/L
Number of subjects: 0
Study 34757600 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 100 U/mL with fasting plasma glucose (FPG) targets ≤ 6.1 mmol/L
Number of subjects: 0
Study 34757600 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 100 U/mL with fasting plasma glucose (FPG) targets ≤ 7.0 mmol/L
Number of subjects: 0
Study 33797477 — intervention group
Group type: EXPERIMENTAL
Intervention: Arch-support foot-orthoses (ASFO)
Number of subjects: 50
Study 33797477 — intervention group
Group type: COMPARATOR
Intervention: Sham flat noncontoured orthoses
Number of subjects: 50
Study 32491233 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine tocodynamometry (IT)
Number of subjects: 1504
Study 32491233 — intervention group
Group type: COMPARATOR
Intervention: External tocodynamometry (ET)
Number of subjects: 1504
Study 35412730 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation
Number of subjects: 73
Study 35412730 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient-based cardiac rehabilitation
Number of subjects: 73
Study 35412730 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 73
Study 33895208 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver reports of putting soil in their mouths at the majority of surveillance visits
Number of subjects: 224
Study 33895208 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver reports of putting visibly dirty objects in their mouths at the majority of visits
Number of subjects: 224
Study 33895208 — intervention group
Group type: EXPERIMENTAL
Intervention: Households with unimproved sanitation
Number of subjects: 224
Study 35485815 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidised dextran (ANDROEXPERT SV1) suppositories, rectally once per day for 10 days, then every other day for 20 days.
Number of subjects: 52
Study 35485815 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cocoa butter) suppositories, rectally in a similar regimen.
Number of subjects: 52
Study 33045783 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D digital simulated design
Number of subjects: 30
Study 33045783 — intervention group
Group type: COMPARATOR
Intervention: 2D digital smile design
Number of subjects: 30
Study 35134930 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 5
Study 35134930 — intervention group
Group type: COMPARATOR
Intervention: Waiting List Group (Control)
Number of subjects: 5
Study 34188125 — intervention group
Group type: EXPERIMENTAL
Intervention: Hangboard group HW (Hang weight, +1.25 kg weight added each week)
Number of subjects: 30
Study 34188125 — intervention group
Group type: EXPERIMENTAL
Intervention: Hangboard group HE (Hang endurance, grips to hold for a determined time decreased every week)
Number of subjects: 30
Study 34188125 — intervention group
Group type: COMPARATOR
Intervention: Control group C (normal climbing training)
Number of subjects: 30
Study 32352341 — intervention group
Group type: EXPERIMENTAL
Intervention: TRT + RT
Number of subjects: 22
Study 32352341 — intervention group
Group type: COMPARATOR
Intervention: TRT
Number of subjects: 22
Study 33652980 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact with family/relatives
Number of subjects: 1365
Study 33652980 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact with friends/neighbors
Number of subjects: 1365
Study 616684312 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser obliteration (laser group, n=20)
Number of subjects: 40
Study 616684312 — intervention group
Group type: COMPARATOR
Intervention: Traditional surgical ligation (traditional group, n=20)
Number of subjects: 40
Study 36123964 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (60 mg/day for 2 weeks)
Number of subjects: 88
Study 36123964 — intervention group
Group type: COMPARATOR
Intervention: Levodropropizine (180 mg/day for 2 weeks)
Number of subjects: 88
Study 35286750 — intervention group
Group type: EXPERIMENTAL
Intervention: RHG + RME (22 patients)
Number of subjects: 44